Nag, S.
Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-17176, Stockholm, Sweden
sangram.nag@ki.se; Varrone, A.
Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-17176, Stockholm, Sweden; Heinrich, T.
Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Lehmann, L.
Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Kettschau, G.
Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Thiele, A.
Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Gulyas, B.
Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-17176, Stockholm, Sweden; Keller, É.
Semmelweis University, Department of Forensic and Insurance Medicine, H-1450 Budapest, Hungary; Halldin, C.
Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-17176, Stockholm, Sweden
(2015-01-22)